LIPOCINE INC. (LPCN) Return on equity 2016–2025
LIPOCINE INC. (LPCN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-66.5%FY2025 · since FY2016: -72.9% → -66.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -66.5% | -66.6 pp |
| FY2024 | 0.0% | +80.3 pp |
| FY2023 | -80.3% | -50.1 pp |
| FY2022 | -30.2% | -28.8 pp |
| FY2021 | -1.4% | +135.3 pp |
| FY2020 | -136.7% | +70.2 pp |
| FY2019 | -206.9% | -83.3 pp |
| FY2018 | -123.6% | -13.0 pp |
| FY2017 | -110.6% | -37.6 pp |
| FY2016 | -72.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice